JP2019516789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516789A5 JP2019516789A5 JP2019510578A JP2019510578A JP2019516789A5 JP 2019516789 A5 JP2019516789 A5 JP 2019516789A5 JP 2019510578 A JP2019510578 A JP 2019510578A JP 2019510578 A JP2019510578 A JP 2019510578A JP 2019516789 A5 JP2019516789 A5 JP 2019516789A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- fulvestrant
- international
- publication
- international publication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021118471A JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
| JP2023086732A JP2023109959A (ja) | 2016-05-06 | 2023-05-26 | フルベストラント配合物およびその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332842P | 2016-05-06 | 2016-05-06 | |
| US62/332,842 | 2016-05-06 | ||
| US201662420555P | 2016-11-10 | 2016-11-10 | |
| US62/420,555 | 2016-11-10 | ||
| PCT/US2017/031376 WO2017193048A1 (en) | 2016-05-06 | 2017-05-05 | Fulvestrant formulations and methods of their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021118471A Division JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019516789A JP2019516789A (ja) | 2019-06-20 |
| JP2019516789A5 true JP2019516789A5 (enExample) | 2020-04-30 |
Family
ID=58709642
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510578A Pending JP2019516789A (ja) | 2016-05-06 | 2017-05-05 | フルベストラント配合物およびその使用方法 |
| JP2021118471A Active JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
| JP2023086732A Pending JP2023109959A (ja) | 2016-05-06 | 2023-05-26 | フルベストラント配合物およびその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021118471A Active JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
| JP2023086732A Pending JP2023109959A (ja) | 2016-05-06 | 2023-05-26 | フルベストラント配合物およびその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20190134059A1 (enExample) |
| EP (1) | EP3452011A1 (enExample) |
| JP (3) | JP2019516789A (enExample) |
| KR (1) | KR102438425B1 (enExample) |
| CN (1) | CN109310621A (enExample) |
| AU (2) | AU2017261321B2 (enExample) |
| CA (1) | CA3022834A1 (enExample) |
| CO (1) | CO2018013257A2 (enExample) |
| IL (2) | IL285928B2 (enExample) |
| MA (1) | MA44862A (enExample) |
| MX (2) | MX2018013414A (enExample) |
| MY (1) | MY205661A (enExample) |
| UA (1) | UA125514C2 (enExample) |
| WO (1) | WO2017193048A1 (enExample) |
| ZA (1) | ZA201807031B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11590077B2 (en) | 2016-05-06 | 2023-02-28 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations and methods of their use |
| KR102670293B1 (ko) * | 2017-11-08 | 2024-05-30 | 이글 파마슈티컬즈 인코포레이티드 | 풀베스트란트 제제 및 그의 사용 방법 |
| EP4074304A4 (en) * | 2019-12-11 | 2024-01-10 | Shanghai Bocimed Pharmaceutical Co., Ltd. | PHARMACEUTICAL COMPOSITION OF FULVESTRANT, PREPARATION METHOD AND APPLICATION THEREOF |
| CN113694017B (zh) * | 2020-05-11 | 2024-04-02 | 鲁南制药集团股份有限公司 | 一种氟维司群注射制剂及其制备方法 |
| CN114504551B (zh) * | 2020-11-16 | 2024-01-02 | 北京厚燊维康科技有限责任公司 | 可用于光动力治疗或诊断的制剂 |
| CN120284882A (zh) * | 2020-12-10 | 2025-07-11 | 上海云晟研新生物科技有限公司 | 氟维司群药物组合物、其制备方法及应用 |
| KR20230094172A (ko) * | 2021-12-20 | 2023-06-27 | 주식회사 삼양홀딩스 | 용해도가 개선된 풀베스트란트의 약학 조성물 및 그 제조 방법 |
| KR20240105964A (ko) * | 2022-12-29 | 2024-07-08 | 주식회사 삼양홀딩스 | 약동학적 특성이 우수한 풀베스트란트의 약학 조성물 및 그 제조 방법 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853260B2 (en) * | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| WO2001087262A2 (en) | 2000-05-15 | 2001-11-22 | Pharmacia Italia S.P.A. | Stabilized steroidal suspension |
| US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
| GB0116619D0 (en) * | 2001-07-07 | 2001-08-29 | Astrazeneca Ab | Formulation |
| HUP0400115A3 (en) * | 2001-07-07 | 2005-11-28 | Astrazeneca Ab | Pharmaceutical composition for the intramuscular administration of fulvestrant |
| JP2003298516A (ja) | 2002-03-29 | 2003-10-17 | Fujitsu Ltd | 波長分散補償装置 |
| PL1778187T3 (pl) | 2004-08-04 | 2012-09-28 | Camurus Ab | Kompozycje tworzące nielamelarne dyspersje |
| MX2007013914A (es) | 2005-05-09 | 2008-02-22 | Biosphere Medical S A | Composiciones y metodos que usan microesferas y agentes de contraste no ionicos. |
| CA2626016A1 (en) | 2005-10-21 | 2007-06-21 | Panacea Biotec Limited | Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| CN101108168B (zh) * | 2007-08-03 | 2010-12-08 | 西安力邦医药科技有限责任公司 | 一种氟维司群缓释微球的制备方法 |
| PL2200588T3 (pl) | 2007-09-25 | 2019-09-30 | Solubest Ltd. | Kompozycje zawierające lipofilowe związki aktywne i sposób ich wytwarzania |
| JP2011514349A (ja) | 2008-03-07 | 2011-05-06 | サイドース・エルエルシー | フルベストラント配合物 |
| TW201016220A (en) * | 2008-10-31 | 2010-05-01 | Scinopharm Taiwan Ltd | Micronization form of 7α-[9-(4,4,5,5,5-pentafluoropentylsufinyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol and process for the preparation thereof |
| EP2442789A1 (en) | 2009-06-18 | 2012-04-25 | Abbott Laboratories | Stable nanoparticulate drug suspension |
| AU2010278601A1 (en) * | 2009-07-31 | 2012-02-23 | Xi'an Libang Medical Technology Co., Ltd | Nanosphere or microsphere drug carrier, preparation method, composition and use thereof |
| CN102264372B (zh) * | 2009-08-31 | 2012-07-11 | 西安力邦医药科技有限责任公司 | 氟维司群纳米球/微球及其制备方法和用途 |
| WO2012021791A2 (en) | 2010-08-13 | 2012-02-16 | Scidose Llc | Aqueous formulation with improved stability |
| EP2616078B1 (en) * | 2010-09-16 | 2019-12-25 | Shimoda Biotech (Pty) Ltd | Fulvestrant compositions and methods of use |
| EP2468258A1 (en) | 2010-12-22 | 2012-06-27 | LEK Pharmaceuticals d.d. | Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient |
| EP2661281B1 (en) | 2011-01-09 | 2021-03-10 | ANP Technologies, Inc. | Hydrophobic molecule-induced branched polymer aggregates and their use |
| CA2836831C (en) * | 2011-05-20 | 2015-06-02 | Capital, Business Y Gestion De Finanzas S.L. | Pharmaceutical composition |
| CN102915088A (zh) | 2011-08-03 | 2013-02-06 | 鸿富锦精密工业（深圳）有限公司 | 资料存储器固定装置 |
| US11179468B2 (en) | 2012-04-09 | 2021-11-23 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations |
| ES2983451T3 (es) | 2012-04-09 | 2024-10-23 | Eagle Pharmaceuticals Inc | Formulaciones de Fulvestrant |
| KR101915942B1 (ko) | 2012-06-08 | 2018-11-06 | 에프. 호프만-라 로슈 아게 | 암의 치료를 위한 포스포이노시타이드 3 키나제 억제제 화합물 및 화학치료제의 돌연변이체 선택성 및 조합물 |
| CN104337761B (zh) * | 2013-08-07 | 2019-03-26 | 江苏豪森药业集团有限公司 | 氟维司群药物组合物 |
| EP3041512A4 (en) * | 2013-09-06 | 2017-05-10 | Ahmed, Salah U. | Fulvestrant compositions |
| CN105745207A (zh) * | 2013-10-03 | 2016-07-06 | 千年药物公司 | 使用PI3Kα抑制剂的增强的治疗方案 |
| HUP1300646A2 (en) | 2013-11-12 | 2015-05-28 | Druggability Technologies Ip Holdco Jersey Ltd | Complexes of fulvestrant and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| PT107433B (pt) | 2014-01-28 | 2018-12-04 | Hovione Farm S A | Processo de redução e controlo do tamanho de partícula |
| US9271990B2 (en) | 2014-02-14 | 2016-03-01 | Fresenius Kabi Usa, Llc | Fulvestrant formulations |
| WO2016004369A1 (en) | 2014-07-02 | 2016-01-07 | The Research Foundation For The State University Of New York | Surfactant-stripped micelle compositions with high cargo to surfactant ratio |
| WO2015018380A2 (en) | 2014-07-03 | 2015-02-12 | Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang)Co., Ltd. | Therapeutic nanoparticles and the preparation methods thereof |
-
2017
- 2017-05-04 IL IL285928A patent/IL285928B2/en unknown
- 2017-05-05 MY MYPI2018703903A patent/MY205661A/en unknown
- 2017-05-05 AU AU2017261321A patent/AU2017261321B2/en active Active
- 2017-05-05 CN CN201780027809.5A patent/CN109310621A/zh active Pending
- 2017-05-05 JP JP2019510578A patent/JP2019516789A/ja active Pending
- 2017-05-05 MX MX2018013414A patent/MX2018013414A/es unknown
- 2017-05-05 MA MA044862A patent/MA44862A/fr unknown
- 2017-05-05 EP EP17723902.7A patent/EP3452011A1/en active Pending
- 2017-05-05 KR KR1020187034942A patent/KR102438425B1/ko active Active
- 2017-05-05 CA CA3022834A patent/CA3022834A1/en active Pending
- 2017-05-05 WO PCT/US2017/031376 patent/WO2017193048A1/en not_active Ceased
- 2017-05-05 US US16/099,265 patent/US20190134059A1/en not_active Abandoned
- 2017-05-05 UA UAA201812019A patent/UA125514C2/uk unknown
-
2018
- 2018-10-18 IL IL262465A patent/IL262465A/en unknown
- 2018-10-22 ZA ZA2018/07031A patent/ZA201807031B/en unknown
- 2018-11-01 MX MX2022013199A patent/MX2022013199A/es unknown
- 2018-12-06 CO CONC2018/0013257A patent/CO2018013257A2/es unknown
-
2021
- 2021-07-19 US US17/379,534 patent/US12370199B2/en active Active
- 2021-07-19 JP JP2021118471A patent/JP7312523B2/ja active Active
-
2023
- 2023-05-26 JP JP2023086732A patent/JP2023109959A/ja active Pending
- 2023-05-31 AU AU2023203392A patent/AU2023203392A1/en not_active Abandoned